Novo Nordisk
NVO
1,512 hedge funds and large institutions have $32.2B invested in Novo Nordisk in 2023 Q4 according to their latest regulatory filings, with 291 funds opening new positions, 581 increasing their positions, 443 reducing their positions, and 59 closing their positions.
393% more first-time investments, than exits
New positions opened: 291 | Existing positions closed: 59
31% more repeat investments, than reductions
Existing positions increased: 581 | Existing positions reduced: 443
21% more call options, than puts
Call options by funds: $719M | Put options by funds: $596M
17% more capital invested
Capital invested by funds: $27.4B → $32.2B (+$4.76B)
16% more funds holding
Funds holding: 1,306 → 1,512 (+206)
13% more funds holding in top 10
Funds holding in top 10: 62 → 70 (+8)
0.26% more ownership
Funds ownership: 8.73% → 9% (+0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
+$374M |
| 2 |
JP Morgan Chase
New York
|
+$265M |
| 3 |
Morgan Stanley
New York
|
+$138M |
| 4 |
Amundi
Paris,
France
|
+$134M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$128M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$235M |
| 2 |
WCM Investment Management
Laguna Beach,
California
|
-$228M |
| 3 |
Jennison Associates
New York
|
-$88.2M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$79.2M |
| 5 |
BlackRock
New York
|
-$74.6M |
NVO Hedge Fund Activity: Q4 2023 in Review
1,512 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2023, worth a combined $32.2B — up 17% from $27.4B a quarter earlier.
Buyers outnumbered sellers: 291 funds opened new NVO positions and 59 closed out — a net gain of 232 holders — while 581 added to existing stakes and 443 trimmed.
The largest buyer was Sustainable Growth Advisers, adding an estimated $374M. The largest seller was Renaissance Technologies, cutting an estimated $235M.
- 1,512 institutional investors held Novo Nordisk (NVO) as of Q4 2023, up from 1,306 in Q3 2023.
- Funds reported $32.2B of Novo Nordisk stock for Q4 2023, up 17% quarter-over-quarter.
- 291 funds opened new Novo Nordisk positions in Q4 2023 and 59 closed out, a net change of +232 holders.
- The largest Novo Nordisk buyer in Q4 2023 was Sustainable Growth Advisers, an estimated $374M added.
- The largest Novo Nordisk seller in Q4 2023 was Renaissance Technologies, an estimated $235M sold.
Based on aggregated 13F filings for Q4 2023.